Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis-Reference-Cited by-同舟云学术

Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis

Published:2023-09 Issue:3 Volume:165 Page:746-761.e16
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Zuo Tao,Xie Qi,Liu Jinfang,Yang Jing,Shi Jiahui,Kong Degang,Wang Yin,Zhang Zhenpeng,Gao Huixia,Zeng Dao-Bing,Wang Xinxin,Tao Ping,Wei Wei,Wang Jun,Li Yuan,Long Qi,Li Chonghui,Chang Lei,Ning Huimin,Li Yanchang,Cui Chunping,Ge Xinlan,Wu Jushan,Li Guangming,Hong Xuechuan,Yang Xiao,Dai Erhei,He Fuchu,Wu Junzhu,Ruan Yuanyuan,Lu Shichun,Xu Ping

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference65 articles.

1. Burden of liver diseases in the world;Asrani;J Hepatol,2019

2. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents;Böttcher;Adv Drug Deliv Rev,2017

3. Recent advancement of molecular mechanisms of liver fibrosis;Seki;J Hepatobiliary Pancreat Sci,2015

4. Remodelling the extracellular matrix in development and disease;Bonnans;Nat Rev Mol Cell Biol,2014

5. Extracellular matrix remodeling in chronic liver disease;Ortiz;Curr Tissue Microenviron Rep,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis;Molecular Metabolism;2024-09

2. Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis;Hepatology;2024-07-23

3. Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers;Communications Biology;2024-07-13

4. Integrative multi-omics analysis reveals cellular and molecular insights into primary Sjögren's syndrome;Heliyon;2024-07

5. Jiawei Taohe Chengqi decoction inhibition of the notch signal pathway affects macrophage reprogramming to inhibit HSCs activation for the treatment of hepatic fibrosis;Journal of Ethnopharmacology;2024-03